Alterity Therapeutics Limited Gains 57.14%
Alterity Therapeutics Limited (ATHE:NASDAQ) soared at $1.87, a gain of 57.1%. On Tue 30 Jun 20, ATHE:NASDAQ touched a New 2-Week High of $1.19. The stock appeared on our News Catalysts scanner on Wed 01 Jul 20 at 11:58 AM in the 'BIOTECH' category. From Tue 16 Jun 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Tue 30 Jun 20 at $1.63 with a volume of 46M+.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- MYOS RENS Technology Inc. (MYOS:NASDAQ), 177.27%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 117.05%
- YRC Worldwide Inc. (YRCW:NASDAQ), 74.59%
- Sunworks, Inc. (SUNW:NASDAQ), 72.13%
- Martin Midstream Partners L.P. (MMLP:NASDAQ), 63.87%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 57.14%
- 89bio, Inc. (ETNB:NASDAQ), 41.34%
- Akero Therapeutics, Inc. (AKRO:NASDAQ), 33.91%
- Luokung Technology Corp. (LKCO:NASDAQ), 29.55%
- Western Copper and Gold Corporation (WRN:NYSEMKT), 28.46%